S Abrignani|D Rosa - JoVE Visualize

Showing results (21-30 of 291) with videos related to

Pageof 30

Sort By:

Archives of Internal Medicine|July 28, 1997

Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trialM Piazza, L Sagliocca, G Tosone, et al.

Bollettino Della Societa Italiana Di Biologia Sperimentale|August 31, 1984

[Activation of the alternative complement pathway by Newcastle disease virus. II) Effects mediated by infected lymphoid cells in vitro]A Salerno, G Colonna Romano, S Abrignani, et al.

Bollettino Della Societa Italiana Di Biologia Sperimentale|August 31, 1984

[Activation of the alternative complement pathway by Newcastle disease virus. I) Effect of the virus on the complement system in vivo and in vitro]F Dieli, G Gallina, S Abrignani, et al.

Virus Research|October 13, 2001

The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptorF Masciopinto, S Campagnoli, S Abrignani, et al.

Nature|August 11, 1988

T cells can present antigens such as HIV gp120 targeted to their own surface moleculesA Lanzavecchia, E Roosnek, T Gregory, et al.

Cellular Immunology|August 1, 1985

Infection of mice with Newcastle disease virus inhibits the T suppressor afferent cell circuit which regulates contact sensitivity to picryl chlorideF Dieli, G Colonna Romano, S Abrignani, et al.

Immunology|March 1, 1986

Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin systemG Colonna Romano, F Dieli, S Abrignani, et al.

The Journal of Experimental Medicine|February 1, 1988

Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targetsA Lanzavecchia, S Abrignani, D Scheidegger, et al.

AIDS (London, England)|December 22, 1999

Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic miceS Toneatto, O Finco, H van der Putten, et al.

European Journal of Immunology|February 13, 2001

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cellsA Wack, E Soldaini, C Tseng, et al.

Pageof 30

Showing results (21-30 of 291) with videos related to

Sort By:

Pageof 30

Archives of Internal Medicine|July 28, 1997

Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trialM Piazza, L Sagliocca, G Tosone, et al.

Bollettino Della Societa Italiana Di Biologia Sperimentale|August 31, 1984

[Activation of the alternative complement pathway by Newcastle disease virus. II) Effects mediated by infected lymphoid cells in vitro]A Salerno, G Colonna Romano, S Abrignani, et al.

Bollettino Della Societa Italiana Di Biologia Sperimentale|August 31, 1984

[Activation of the alternative complement pathway by Newcastle disease virus. I) Effect of the virus on the complement system in vivo and in vitro]F Dieli, G Gallina, S Abrignani, et al.

Virus Research|October 13, 2001

The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptorF Masciopinto, S Campagnoli, S Abrignani, et al.

Nature|August 11, 1988

T cells can present antigens such as HIV gp120 targeted to their own surface moleculesA Lanzavecchia, E Roosnek, T Gregory, et al.

Cellular Immunology|August 1, 1985

Infection of mice with Newcastle disease virus inhibits the T suppressor afferent cell circuit which regulates contact sensitivity to picryl chlorideF Dieli, G Colonna Romano, S Abrignani, et al.

Immunology|March 1, 1986

Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin systemG Colonna Romano, F Dieli, S Abrignani, et al.

The Journal of Experimental Medicine|February 1, 1988

Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targetsA Lanzavecchia, S Abrignani, D Scheidegger, et al.

AIDS (London, England)|December 22, 1999

Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic miceS Toneatto, O Finco, H van der Putten, et al.

European Journal of Immunology|February 13, 2001

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cellsA Wack, E Soldaini, C Tseng, et al.

Pageof 30